Yessss!!!!! ASCO community, we must advocate for ourselves to make this happen. Do this 👇 today. Thank you Tatiana Prowell, MD for your guidance.

.Mayo Clinic oncologist Dr. Karthik Giridhar talks with OncLive.com about findings from an exploratory analysis of the phase 1 EMBER trial for patients with advanced or metastatic #BreastCancer or #EndometrialCancer. #ESMO24 bit.ly/3zhQQt1

A poignant piece of writing. And sadly, exceedingly accurate. Our system is failing our most vulnerable.

Paolo Tarantino Sara Tolaney Dana-Farber’s Breast Oncology Center Aleix Prat #PrecisionOncology Translational Breast Cancer Research Consortium Dana-Farber News Guillermo Villacampa Ann Partridge MD, MPH Harold J. Burstein, MD, PhD, FASCO Hope Rugo Journal of Clinical Oncology Congrats Paolo Tarantino Sara Tolaney and Dana-Farber team!

Applications for Conquer Cancer research grants and awards are now open! Funding is available for researchers at every career stage. Learn more and apply now! brnw.ch/21wL4uc ASCO #OncAlert #ConquerCancer

🚨 Our study in Frontiers - Oncology reveals a novel positive feedback loop between AURKA and PD-L1 in triple negative breast cancer. Dual blockade shows promise in inhibiting tumor growth and metastasis. frontiersin.org/journals/oncol… #CancerResearch #TNBC #Oncology

HR +ve HER2 -VE MBC . Money 💰 slide . All treatment strategies in one slide ESMO - Eur. Oncology #ESMOdeepdive

Thanks to the The ASCO Post for featuring our JCO publication of the #ATEMPT 5y update! With <1% risk of distant recurrence at 5 years & improved quality of life over chemo, adjuvant T-DM1 should be considered as a valid alternative to TH for stage I HER2+ BC. ascopost.com/news/july-2024…

Optimal Anastrozole Dose for Estrogen Suppression in Postmenopausal Breast Cancer oncodaily.com/108556.html Tufia Haddad, Brenda Ernst, MD, Zeruesenay Desta, Roberto Leon-Ferre, Kathryn Ruddy, Matthew Goetz #Oncology #Cancer #ResearchPapers #BreastCancer #BCSM #Postmenopausal

👏 Join us in congratulating our members who earned the Fellows of ASCO (FASCO) distinction this quarter! We're grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wLvZf

Documenting “ecchymosis” instead of “bruise”

👩🏽‍🏫 my ASCO TECAG colleagues and I put together this workbook on the what, when, why, and how of mentoring for #hemeonc trainees and early career physicians Check it out 👀 and let us know how you’ve been able to form effective mentoring relationships! ASCO Hem-Onc Fellows Network

📣Linda oportunidad para todos los oncólogos jovenes de LATAM para conocer la experiencia de 2 grandes especialistas sobre investigación y ensayos clínicos en escenarios con recursos limitados. Los esperamos!!! ESMO - Eur. Oncology #ESMOYOC

Excited to see our review published! Thank you Jame Abraham, MD, FACP and Erin Roesch for all your guidance and support! JCO Oncology Practice

HUGE 💣 news for IMGs! The American Board of internal medicine is considering a pathway that allows American BOARD certification with just a fellowship in the U.S. without U.S. residency!

Thank you to our Cleveland Clinic colleagues for the invitation to speak and share our experience with Robotic Nipple Sparing Mastectomy Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery Mayo Clinic

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

Great job Daniel Stover, MD, FASCO 🎉